Joe Gray, PhD
Oregon Health & Science University, Knight Cancer Institute, Portland
Dr. Gray is a highly regarded scientist best known for breakthroughs that have changed clinical practices for cancer patients, including aspects of flow cytometry. His expertise lies in molecular analysis technology, identification of genomic aberrations that contribute to cancer pathophysiology, and development of efficient strategies for enhanced marker-guided cancer therapy—especially for breast and ovarian cancer. He helped to develop the widely used fluorescence in situ hybridization and comparative genomics hybridization tests that map the genetic material in breast cancer patients’ cells. His research currently explores mechanisms by which genomic, transcriptional, and proteomic abnormalities occur in selected cancers.
The Impact of Measurement Science on Cancer Management
Cancer Center Director Michelle Le Beau, PhD, and Joe Gray, PhD